Vancomycin Relieves Mycophenolate Mofetil–induced Gastrointestinal Toxicity by Eliminating Gut Bacterial Β-Glucuronidase Activity

Science advances - United States
doi 10.1126/sciadv.aax2358
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for the Advancement of Science (AAAS)

Related search

Targeted Inhibition of Gut Bacterial Β-Glucuronidase Activity Enhances Anticancer Drug Efficacy

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2020English

Is Conversion From Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium Justifiable for Gastrointestinal Quality of Life?

Drugs in R and D
Pharmacology
2018English

Mycophenolate Mofetil for Drug-Induced Vanishing Bile Duct Syndrome

World Journal of Gastroenterology
MedicineGastroenterology
2007English

Down-Regulation of Multiple Low Dose Streptozotocin-Induced Diabetes by Mycophenolate Mofetil

Clinical and Experimental Immunology
AllergyImmunology
2002English

Mycophenolate Mofetil Induced Remission in Steroid-Refractory Autoimmune Hemolytic Anemia

Meandros Medical and Dental Journal
2018English

Immunosuppression of Experimental Autoimmune Myasthenia Gravis by Mycophenolate Mofetil

Journal of Neuroimmunology
AllergyImmunologyNeurology
2008English

Transient Improvement of Hypertension-Induced Chronic Renal Failure With Mycophenolate Mofetil Treatment

Renal Failure
MedicineNephrologyCritical CareIntensive Care Medicine
2006English

Β-Glucuronidase (GUS)

Science-Business eXchange
2008English

Β-Glucuronidase (GUSB)

Science-Business eXchange
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy